tiprankstipranks
RepliCel Life Sciences Inc (REPCF)
OTHER OTC:REPCF
US Market
REPCF
RepliCel Life Sciences
RESEARCH TOOLSreports
Want to see REPCF full AI Analyst Report?

RepliCel Life Sciences (REPCF) Financial Statements

22 Followers

RepliCel Life Sciences Financial Overview

RepliCel Life Sciences's market cap is currently $767.50K. The company's EPS TTM is $0; its P/E ratio is -0.02; RepliCel Life Sciences is scheduled to report earnings on August 27, 2025, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Mar 24Mar 23Mar 22
Income Statement
Total RevenueC$ 353.44KC$ 353.74KC$ 353.74KC$ 353.74KC$ 353.74K
Gross ProfitC$ 0.00C$ 353.74KC$ 352.26KC$ 353.74KC$ 353.74K
Operating IncomeC$ 237.84KC$ -360.00KC$ -1.39MC$ -1.39MC$ -2.30M
EBITDAC$ 237.84KC$ -359.46KC$ -1.39MC$ -736.00KC$ -4.07M
Net IncomeC$ -401.63KC$ -97.29KC$ -312.00KC$ -743.00KC$ -4.07M
Balance Sheet
Cash & Short-Term InvestmentsC$ 5.52KC$ 1.81KC$ 76.41KC$ 430.27KC$ 238.44K
Total AssetsC$ 97.01KC$ 147.10KC$ 287.79KC$ 798.22KC$ 591.79K
Total DebtC$ 1.02MC$ 681.59KC$ 873.19KC$ 40.96KC$ 34.26K
Net DebtC$ 1.02MC$ 679.78KC$ 814.03KC$ -372.07KC$ -186.93K
Total LiabilitiesC$ 5.01MC$ 4.66MC$ 4.82MC$ 6.71MC$ 7.43M
Stockholders' EquityC$ -4.91MC$ -4.51MC$ -4.53MC$ -5.92MC$ -6.84M
Cash Flow
Free Cash FlowC$ -296.08KC$ -530.86KC$ -1.41MC$ -1.41MC$ -2.51M
Operating Cash FlowC$ -296.08KC$ -530.86KC$ -1.41MC$ -1.41MC$ -2.51M
Investing Cash FlowC$ 0.00C$ 17.25KC$ 0.00C$ 0.00C$ 0.00
Financing Cash FlowC$ 299.80KC$ 456.25KC$ 1.06MC$ 1.60MC$ 2.70M
Currency in CAD

RepliCel Life Sciences Earnings and Revenue History

Income Statement >

RepliCel Life Sciences Debt to Assets

Balance Sheet >

RepliCel Life Sciences Cash Flow

Cash Flow >

RepliCel Life Sciences Forecast EPS vs Actual EPS

Earnings >